76 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
Clinical Trials of SGLT2 ... ASCVD; signal for SGLT2i ... risk; signal for SGLT2i ... HF outcomes in HFrEF ... HF outcomes in HFrEF
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
comparison between SGLT ... (Steglatro) #diabetes ... cardiovascular #renal #SGLT2i
Diabetes Combination Tablets - Estimated A1c Lowering 
Metformin + DPP4 
• Janumet (metformin + sitagliptin) 
•
Diabetes Combination ... Metformin + SGLT2 ... dapagliflozin) Dpp4 + SGLT2 ... /ambcarerx #Diabetes ... Tablets #Oral #DM2
#diabetes #T2DM #antidiabeticagents #oraldiabeticagents

FIGURE 9.1 Glucose-lowering medication in type 2 diabetes: overall approach. For appropriate context,
#diabetes #T2DM ... receptor agonist; SGLT2i ... , SGLT2 inhibitor ... Diabetes Care 2018 ... Diabetes Care 19
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... -4 inhibitors SGLT2 ... EricsMedicalLectures/featured #diabetes ... endocrinology #dm2
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... Action: Inhibits SGLT2 ... • Euglycemic diabetic ... Pharmacology #Summary #DM2 ... #diabetes #endocrinology
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
commonly used diabetic ... #pharmacology #dm2 ... #diabetes #medications
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
resynchronization therapy; DM ... , diabetes mellitus ... heart failure; HFpEF ... ejection fraction; HFrEF
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... SGLT2 inhibitors ... class of anti-diabetic ... #Medications #DM2 ... #Diabetes #Endocrinology
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Stable Angina, HFpEF ... , HFrEF, AFib, TAA ... Dissection • CKD, DM